The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to [...] READ MORE ...

Two PanCAN Patient Services Senior Case Managers share their thoughts on the importance of caregiving—and how we can all support the selfless, special caregivers in our lives.

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

Advocate. Note-taker. Cook. Shoulder to lean on. Caregivers for people facing pancreatic cancer fill many different roles. Although every person’s story is unique, there’s value in learning from ...

We're the national organization providing support, resources, volunteer opportunities and hope for people fighting pancreatic cancer.

Cancer advocates, researchers, clinicians and patients are speaking out in a new STAT News article published this week about the devastating impact the cuts to federal research funding will have on ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit outlines the latest advances in pancreatic cancer and offers key insights from ASCO GI 2025.

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and treating pancreatic cancer in 2024.

The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called NRG1 gene fusion found in roughly 3% of patients with pancreatic ...

In a Phase III clinical trial, a therapy known as Tumor Treating Fields (TTFields) increased survival for patients whose pancreatic cancer had not spread to other organs but cannot be removed by ...